Cormorant Asset Management, Other: Bright Minds Biosciences DRUG Sell · Filed 04/30

Trade details

Type: Insider sale
Amount: $9,785,124.5
Shares · price: 109,331 sh · $89.50 a share
Held after: 950,000 sh
Stock: Bright Minds Biosciences DRUG
Person: Cormorant Asset ManagementOther
Trade date: 26/04/28
Filed: 26/04/30
Days to filing: 2 days

Sold 10.3% of holdings

Share of holding sold: 10.3%

Bright Minds Biosciences trades, last 26 weeks

What else happened in Bright Minds Biosciences around then

Filed or reported within 30 days of the trade day · 03/29~05/28

Cormorant Asset Management's recent trades

Cormorant Asset Management10% Owner
SellCorbus Pharmaceuticals Holdings
Sell
Corbus Pharmaceuticals Holdings
CRBP
$344.1K
30,029 sh
$344.1K
Filed 25/12/15
Traded 25/12/11
Cormorant Asset ManagementOther
SellEyePoint
Sell
EyePoint
EYPT
$942K
60,000 sh
$942K
Filed 25/12/08
Traded 25/12/04
Cormorant Asset ManagementOther
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$25.7M
3,390,943 sh
$25.7M
Filed 25/10/01
Traded 25/09/29
Cormorant Asset ManagementOther
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$18.5M
2,800,000 sh
$18.5M
Filed 25/10/01
Traded 25/09/29
Cormorant Asset ManagementOther
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$2M
232,460 sh
$2M
Filed 25/10/01
Traded 25/09/29

Cormorant Asset Management, Other — sold $9.8M of Bright Minds Biosciences DRUG · 10.3% of holdings | Whalegun